Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Brazil receives reduced Kaletra price
The new agreement sets the price for the protease inhibitor at $1,000 per patient per year. Last month, Brazil’s president Luiz Inacio Lula da Silva announced that the
The new agreement sets the price for the protease inhibitor at $1,000 per patient per year. Last month, Brazil’s president Luiz Inacio Lula da Silva announced that the
In preclinical studies, PX-478 produced significant tumor regression and growth delay in multiple models of human cancers, including cancers of the lung, breast, prostate, colon, kidney, pancreas and
The company will receive approximately $4 million as a result of the sale of its Ontario facility, and approximately $21 million from the sale of its former Salt
Maryland-based MedImmune said it has begun dosing at-risk children six months to 24 months of age in a phase I trial of a vaccine designed to help prevent
Avanir said in light of the reduced operating infrastructure anticipated following the sale of FazaClo, Mike Puntoriero, senior vice president and CFO, will be resigning his position. Martin
The drug, EPC2407, belongs to a novel class of microtubulin inhibitors discovered by New York drug developer EpiCept. These compounds cause caspase activation, cell cycle arrest, and apoptotic
The National Institute for Health and Clinical Excellence (NICE) has approved the drug, despite concerns over its high cost and clinical effectiveness. The recommendation reverses an earlier decision
The study reports that for patients taking Tarceva who developed a moderate to severe rash, survival without progression of disease was 245% longer than in patients who had
The phase IIb cancer cachexia trial is a randomized, double blind, placebo controlled study of muscle wasting in 150 patients with non-small cell lung cancer, colorectal cancer, non-Hodgkin’s
The company says the 75mg capsules for treating adults and the liquid form of Tamiflu will continue to be available. The shelf life of the capsules is 5